| pubmed-article:16162148 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:16162148 | lifeskim:mentions | umls-concept:C0241910 | lld:lifeskim |
| pubmed-article:16162148 | lifeskim:mentions | umls-concept:C0054201 | lld:lifeskim |
| pubmed-article:16162148 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:16162148 | pubmed:dateCreated | 2005-9-15 | lld:pubmed |
| pubmed-article:16162148 | pubmed:abstractText | Autoimmune hepatitis (AIH) is a chronic liver disease that is effectively treated with immunosuppressive therapy. Predniso(lo)ne, often in combination with azathioprine, is the basic therapeutic option to induce remission. However, this regimen can cause numerous side effects. The aim of the present study was to evaluate budesonide as a treatment option in the induction of remission in patients with previously untreated AIH. | lld:pubmed |
| pubmed-article:16162148 | pubmed:language | eng | lld:pubmed |
| pubmed-article:16162148 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16162148 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:16162148 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16162148 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16162148 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:16162148 | pubmed:month | Oct | lld:pubmed |
| pubmed-article:16162148 | pubmed:issn | 1478-3223 | lld:pubmed |
| pubmed-article:16162148 | pubmed:author | pubmed-author:MannsMichael... | lld:pubmed |
| pubmed-article:16162148 | pubmed:author | pubmed-author:JansenPeter... | lld:pubmed |
| pubmed-article:16162148 | pubmed:author | pubmed-author:SpenglerUlric... | lld:pubmed |
| pubmed-article:16162148 | pubmed:author | pubmed-author:HochhausGünth... | lld:pubmed |
| pubmed-article:16162148 | pubmed:author | pubmed-author:BeuersUlrichU | lld:pubmed |
| pubmed-article:16162148 | pubmed:author | pubmed-author:LohseAnsgarA | lld:pubmed |
| pubmed-article:16162148 | pubmed:author | pubmed-author:KreiselWolfga... | lld:pubmed |
| pubmed-article:16162148 | pubmed:author | pubmed-author:KoletzkoSibyl... | lld:pubmed |
| pubmed-article:16162148 | pubmed:author | pubmed-author:SchülerAndrea... | lld:pubmed |
| pubmed-article:16162148 | pubmed:author | pubmed-author:WiegandJohann... | lld:pubmed |
| pubmed-article:16162148 | pubmed:author | pubmed-author:KanzlerStepha... | lld:pubmed |
| pubmed-article:16162148 | pubmed:author | pubmed-author:MöllmannHelmu... | lld:pubmed |
| pubmed-article:16162148 | pubmed:author | pubmed-author:PrölsMarkusM | lld:pubmed |
| pubmed-article:16162148 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:16162148 | pubmed:volume | 25 | lld:pubmed |
| pubmed-article:16162148 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:16162148 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:16162148 | pubmed:pagination | 927-34 | lld:pubmed |
| pubmed-article:16162148 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:16162148 | pubmed:meshHeading | pubmed-meshheading:16162148... | lld:pubmed |
| pubmed-article:16162148 | pubmed:meshHeading | pubmed-meshheading:16162148... | lld:pubmed |
| pubmed-article:16162148 | pubmed:meshHeading | pubmed-meshheading:16162148... | lld:pubmed |
| pubmed-article:16162148 | pubmed:meshHeading | pubmed-meshheading:16162148... | lld:pubmed |
| pubmed-article:16162148 | pubmed:meshHeading | pubmed-meshheading:16162148... | lld:pubmed |
| pubmed-article:16162148 | pubmed:meshHeading | pubmed-meshheading:16162148... | lld:pubmed |
| pubmed-article:16162148 | pubmed:meshHeading | pubmed-meshheading:16162148... | lld:pubmed |
| pubmed-article:16162148 | pubmed:meshHeading | pubmed-meshheading:16162148... | lld:pubmed |
| pubmed-article:16162148 | pubmed:meshHeading | pubmed-meshheading:16162148... | lld:pubmed |
| pubmed-article:16162148 | pubmed:year | 2005 | lld:pubmed |
| pubmed-article:16162148 | pubmed:articleTitle | Budesonide in previously untreated autoimmune hepatitis. | lld:pubmed |
| pubmed-article:16162148 | pubmed:affiliation | Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Carl-Neuberg-Strasse 1, 30625 Hannover, Germany. | lld:pubmed |
| pubmed-article:16162148 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:16162148 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:16162148 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| pubmed-article:16162148 | pubmed:publicationType | Clinical Trial, Phase II | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16162148 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16162148 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16162148 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16162148 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16162148 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16162148 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16162148 | lld:pubmed |
